Medical Marijuana Inc (MJNA)

[DropLine]

Everyone is Watching Medical Marijuana Inc (OTCMKTS:MJNA)

Medical Marijuana Inc (OTCMKTS:MJNA) continues to be amongst the top traded stocks on the bb’s recently making a big move up off its $0.06 base to highs over $0.11 after they announced strong operating results and a significant increase in revenues.

MJNA has a long history of spectacular movies running as high as $0.50 in 2013. This is a stock that knows how to market itself and get itself into the main stream media and deserves to be at the top of Investors watch lists anytime it starts trading big volume.

Medical Marijuana Inc (OTCMKTS:MJNA) is one of the first pot stocks that has been around since the beginning. The Company has made a number of acquisitions in the cannabis sector that drive future growth.

MJNA most profitable division is HempMeds, an exclusive master distributor for MJNA that provides cannabidiol (CBD) products made from industrial hemp that are already available in all 50 states and more than 40 countries. The unit boasts fast growing revenues and reported $2,876,438 in sales in Q3.

MJNA recently announced its 2014 Annual Report last week, MJNA said ”The Company continued to have exceptional growth over the year with product sales total of over $14,522,892 compared to $5,059,924 for the prior year, representing a sales increase of more than 280%.

Operating highlights for the year included:

Overall consolidated product sales income of $14,522,892 compared to $5,059,924 for the year ending 2013

Maintained a note-based line of credit with $6,000,000 in available reserves

Increased its merchant accounts monthly processing ability to over $20,000,000

The Company, through its licensing agreement with CannaVest, has held seasoned securities valued at over $8,000,000 (at close of 2014)

Completed its expansion to a new sales, marketing and logistics center in order to accommodate continued and rapid growth

Completed one of the largest acquisitions in industry history with the purchase of direct sales company Kannaway

MJNA says their HempMeds™ sales operation has been greatly streamlined and they have cut back on inefficient expenses. The world is waking up to the vast untapped potential of cannabinoid-rich hemp oil and our flagship product, Real Scientific Hemp Oil™ (RSHO™), continues to show increasing demand. Combining our reduced manufacturing costs with improving demand from lower retail prices – we expect to see improving gross margins as the year progresses. Over the course of the last year we have been able to decrease our retail sales price by over 30% while still increasing margins and overall volume.”

Last month Project CBD, a California educational nonprofit that focuses on cannabis science and therapeutics published an article called HEMP OIL HUSTLERS; Medical Marijuana Inc., HempMeds & Kannaway that has raised a stir especially with MJNA management who filed a $100 million lawsuit. As per the recent shareholder letter ”To date, two parties have settled in our litigation.”

On May 18 MJNA said ”HempMeds Brasil’s™ RSHO™ product has been written into world history as the first cannabis product to be approved for import by Brazil’s federal government and used as a prescription for approved medical indications within Brazil including epilepsy (CDKL5 and Dravet Syndrome). HempMeds Brasil™ is providing the RSHO™ exclusively for the Brazilian marketplace while under temporary broad approval for additional medical indications, subject to clinical trials within the country.